Lakmini Senavirathna
-
- Cancer-related molecular mechanisms research 4
- MicroRNA in disease regulation 2
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 7
- Radiation Therapy and Dosimetry 2
-
- Metabolomics and Mass Spectrometry Studies 2
-
- Advanced Glycation End Products research 3
-
- Autophagy in Disease and Therapy 2
-
- Nanoparticle-Based Drug Delivery 2
- Partner nations
- United StatesChinaRussia
In The Last Decade
Lakmini Senavirathna
19 papers receiving 444 citations
Peers
Comparison fields: 5 of 76
- Cancer Research 142
- Pulmonary and Respiratory Medicine 143
- Molecular Biology 234
- Clinical Biochemistry 19
- Immunology 47
Countries citing papers authored by Lakmini Senavirathna
This map shows the geographic impact of Lakmini Senavirathna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lakmini Senavirathna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lakmini Senavirathna more than expected).
Fields of papers citing papers by Lakmini Senavirathna
This network shows the impact of papers produced by Lakmini Senavirathna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lakmini Senavirathna. The network helps show where Lakmini Senavirathna may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lakmini Senavirathna, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 4 | |
| 5 | 2022 | 10 | |
| 6 | 2022 | 4 | |
| 7 | 2021 | 12 | |
| 8 | 2021 | 9 | |
| 9 | 2021 | 17 | |
| 10 | 2020 | 20 | |
| 11 | 2019 | 46 | |
| 12 | 2019 | 29 | |
| 13 | 2018 | 68 | |
| 14 | 2017 | 39 | |
| 15 | 2017 | 36 | |
| 16 | 2016 | 1 | |
| 17 | 2016 | 54 | |
| 18 | 2014 | 54 | |
| 19 | 2014 | 6 | |
| 20 | 2013 | 31 |
About Lakmini Senavirathna
Lakmini Senavirathna is a scholar working on Clinical Biochemistry, Cancer Research and Pulmonary and Respiratory Medicine, having authored 20 papers that have together received 447 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Cancer-related molecular mechanisms research (4 papers), Advanced Glycation End Products research (3 papers), Metabolomics and Mass Spectrometry Studies (2 papers), MicroRNA in disease regulation (2 papers), Autophagy in Disease and Therapy (2 papers), Nanoparticle-Based Drug Delivery (2 papers) and Radiation Therapy and Dosimetry (2 papers). The work is most often cited by research in Cancer Research (142 citations), Pulmonary and Respiratory Medicine (143 citations) and Molecular Biology (234 citations). Lakmini Senavirathna has collaborated with scholars based in United States, China and Russia. Frequent co-authors include Lin Liu, Chaoqun Huang, Xuxu Gou, Yurong Liang, Xiaoyun Yang, Roshini Sathiaseelan, Sheng Pan, Ru Chen, Chunling Zhao and Craig A. Henke. Their work appears in journals such as Development, Biochemistry and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.